UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044328 |
|---|---|
| Receipt number | R000050630 |
| Scientific Title | Screening for ischemic heart disease in HIV-infected patients |
| Date of disclosure of the study information | 2021/05/28 |
| Last modified on | 2023/05/02 17:06:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Screening for ischemic heart disease in HIV-infected patients
Acronym
HAIHD
Scientific Title
Screening for ischemic heart disease in HIV-infected patients
Scientific Title:Acronym
HAIHD
Region
| Japan |
Condition
Condition
HIV
Ischemic Heart Disease
Classification by specialty
| Cardiology | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Coronary CT in non-hemophiliac HIV-infected patients to determine the prevalence of ischemic heart disease
Basic objectives2
Others
Basic objectives -Others
Prospective observational study
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Prevalence of Ischemic Heart Disease in Non-Hemophilic HIV-Infected Patients
Key secondary outcomes
Evaluation for correlation between risk factors for ischemic heart disease and ischemic heart disease in non-hemophilia HIV-infected patients and usefulness of screening test
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Other |
Interventions/Control_1
Coronary CT
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Individuals who have given written consent to participate in the research.
(2) Males and females aged 20 years or older at the time of obtaining consent
(3) Those with a positive anti-HIV antibody test result.
Key exclusion criteria
(1) Patients who have been diagnosed with ischemic heart disease
(2) Patients who have been diagnosed with hemophilia
(3) Patients with a history of hypersensitivity to iodine or iodine contrast media
(4) Persons with serious thyroid disease
(5) Patients with severe bronchial asthma
6) Patients with severe cardiac disorders
7) Patients with severe hepatic impairment
8) Patients with severe renal dysfunction
9) Patients with macroglobulinemia
10) Patients with multiple myeloma
11) Patients with tetany
12) Patients with pheochromocytoma or suspected pheochromocytoma
13) Patients of childbearing potential
14) Those who are judged by the principal investigator to be inappropriate for inclusion in the study
Target sample size
70
Research contact person
Name of lead principal investigator
| 1st name | Yukio |
| Middle name | |
| Last name | Hiroi |
Organization
National Center for Global Health and Medicine
Division name
Cardiology
Zip code
1628655
Address
1-21-1, Toyama, Shinjuku-ku Tokyo 162-8655, Japan
TEL
03-3202-7181
yhiroi@hosp.ncgm.go.jp
Public contact
Name of contact person
| 1st name | Yukio |
| Middle name | |
| Last name | Hiroi |
Organization
National Center for Global Health and Medicine
Division name
Cardiology
Zip code
1628655
Address
1-21-1, Toyama, Shinjuku-ku Tokyo 162-8655, Japan
TEL
03-3202-7181
Homepage URL
yhiroi@hosp.ncgm.go.jp
Sponsor or person
Institute
National Center for Global Health and Medicine
Institute
Department
Personal name
Funding Source
Organization
National Center for Global Health and Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Division of Medical Research Management, Management and Planning Bureau National Center for Global Health and Medicine
Address
1-21-1, Toyama, Shinjuku-ku Tokyo 162-8655, Japan
Tel
03-3202-7181
rinrijm@hosp.ncgm.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立国際医療研究センター病院
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 05 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 04 | Month | 09 | Day |
Date of IRB
| 2021 | Year | 04 | Month | 09 | Day |
Anticipated trial start date
| 2021 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2023 | Year | 01 | Month | 31 | Day |
Date trial data considered complete
| 2023 | Year | 01 | Month | 31 | Day |
Date analysis concluded
| 2023 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2021 | Year | 05 | Month | 26 | Day |
Last modified on
| 2023 | Year | 05 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050630
